Karolinska Development AB Company Description

Karolinska Development AB (publ) is a venture capital firm specializing in investments in growth capital, seed stage, and early stage companies.

It seeks to invest in pharmaceutical research and development, medical research, medical innovations, healthcare technology, gene research and development, drug delivery technologies, biotechnology, and life science tools and service sectors.

The firm seeks to invest in the Nordic region with a focus on Sweden, Iceland, Norway, Finland, and Denmark.

It prefers to be a lead investor in its portfolio companies however does consider co-investments also.

It seeks to invest in up to five projects annually. Karolinska Development AB (publ) was founded in 2003 and is headquartered in Stockholm, Sweden.

Karolinska Development AB (publ)

Country	Sweden
Founded	2003
Industry	Biotechnology
Sector	Healthcare
Employees	8
CEO	Viktor Drvota

Contact Details

Address: Nanna Svartz väg 6A Solna, 17165 Sweden
Phone	46 8 524 860 70
Website	karolinskadevelopment.com

Stock Details

Ticker Symbol	KDEV
Exchange	Nasdaq Stockholm
Fiscal Year	January - December
Reporting Currency	SEK
ISIN Number	SE0002190926
SIC Code	2836

Key Executives

Name	Position
Johan Dighed	Chief Legal Officer and Deputy Chief Executive Officer
Dr. Viktor Drvota M.D., Ph.D.	Chief Executive Officer
Hans Christopher Toll	Chief Financial Officer
Per Aniansson	Investment Director
Eva Montgomerie	Head of Accounting
Dr. John Öhd M.D., Ph.D.	Chief Scientific Officer and Venture Partner
Yan Cheng	President of Asia
Tse Ping	Senior Strategic Advisor
Linda Spahiu	Investment Manager
Mikaela Sörman	Investment Manager